A CT-based radiomics nomogram for differentiation of renal oncocytoma and chromophobe renal cell carcinoma with a central scar-matched study

被引:0
|
作者
Li, Xiaoli [1 ]
Ma, Qianli [2 ]
Nie, Pei [1 ]
Zheng, Yingmei [3 ]
Dong, Cheng [1 ]
Xu, Wenjian [1 ]
机构
[1] Qingdao Univ, Dept Radiol, Affiliated Hosp, Qingdao, Shandong, Peoples R China
[2] Qingdao Municipal Hosp, Dept Radiol, Qingdao, Shandong, Peoples R China
[3] Qingdao Univ, Affiliated Hosp, Hlth Management Ctr, Qingdao, Shandong, Peoples R China
来源
BRITISH JOURNAL OF RADIOLOGY | 2022年 / 95卷 / 1129期
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Objective: Pre-operative differentiation between renal oncocytoma (RO) and chromophobe renal cell carcinoma (chRCC) is critical due to their different clinical behavior and different clinical treatment decisions. The aim of this study was to develop and validate a CT-based radiomics nomogram for the pre-operative differentiation of RO from chRCC.Methods: A total of 141 patients (84 in training data set and 57 in external validation data set) with ROs (n = 47) or chRCCs (n = 94) were included. Radiomics features were extracted from tri-phasic enhanced-CT images. A clinical model was developed based on significant patient characteristics and CT imaging features. A radiomics signature model was developed and a radiomics score (Rad-score) was calculated. A radiomics nomogram model incorporating the Rad-score and independent clinical factors was developed by multivariate logistic regression analysis. The diagnostic performance was evaluated and validated in three models using ROC curves.Results: Twelve features from CT images were selected to develop the radiomics signature. The radiomics nomogram combining a clinical factor (segmental enhancement inversion) and radiomics signature showed an AUC value of 0.988 in the validation set. Decision curve analysis revealed that the diagnostic performance of the radiomics nomogram was better than the clinical model and the radiomics signature.Conclusions: The radiomics nomogram combining clinical factors and radiomics signature performed well for distinguishing RO from chRCC.Advances in knowledge: Differential diagnosis between renal oncocytoma (RO) and chromophobe renal cell carcinoma (chRCC) is rather difficult by conventional imaging modalities when a central scar was present. A radiomics nomogram integrated with the radiomics signature, demographics, and CT findings facilitates differentiation of RO from chRCC with improved diagnostic efficacy. The CT-based radiomics nomogram might spare unnecessary surgery for RO.Advances in knowledge: Differential diagnosis between renal oncocytoma (RO) and chromophobe renal cell carcinoma (chRCC) is rather difficult by conventional imaging modalities when a central scar was present. A radiomics nomogram integrated with the radiomics signature, demographics, and CT findings facilitates differentiation of RO from chRCC with improved diagnostic efficacy. The CT-based radiomics nomogram might spare unnecessary surgery for RO.Advances in knowledge: Differential diagnosis between renal oncocytoma (RO) and chromophobe renal cell carcinoma (chRCC) is rather difficult by conventional imaging modalities when a central scar was present. A radiomics nomogram integrated with the radiomics signature, demographics, and CT findings facilitates differentiation of RO from chRCC with improved diagnostic efficacy. The CT-based radiomics nomogram might spare unnecessary surgery for RO.
引用
收藏
页数:10
相关论文
共 50 条
  • [31] Bioactive peptide metabolism in renal chromophobe cell carcinoma and in oncocytoma
    Perez-Urzelai, I.
    Blanco, L.
    Casis, L.
    Etxezarraga, M. C.
    Larrinaga, G.
    Varona, A.
    [J]. NEUROPEPTIDES, 2008, 42 (04) : 495 - 496
  • [32] Carbonic anyhdrase II in oncocytoma and chromophobe renal cell carcinoma
    Weinrach, DM
    Wang, KL
    Papavero, V
    Lin, B
    Teh, BT
    Yang, XJ
    [J]. LABORATORY INVESTIGATION, 2005, 85 : 172A - 172A
  • [33] Hybrid oncocytic/chromophobe renal tumors are molecularly distinct from oncocytoma and chromophobe renal cell carcinoma
    Ruiz-Cordero, Roberto
    Rao, Priya
    Li, Lerong
    Qi, Yuan
    Atherton, Daniel
    Peng, Bo
    Singh, Rajesh R.
    Kim, Tae-Beom
    Kawakami, Fumi
    Routbort, Mark J.
    Alouch, Nail
    Chow, Chi-Wan B.
    Tang, Ximing
    Lu, Wei
    Brimo, Fadi
    Matin, Surena F.
    Wood, Christopher G.
    Tannir, Nizar M.
    Wistuba, Ignacio I.
    Chen, Ken
    Wang, Jing
    Medeiros, L. Jeffrey
    Karam, Jose A.
    Tamboli, Pheroze
    Sircar, Kanishka
    [J]. MODERN PATHOLOGY, 2019, 32 (11) : 1698 - 1707
  • [34] Discrimination of oncocytoma and chromophobe renal cell carcinoma using MRI
    Akin, Isil Basara
    Altay, Canan
    Guler, Ezgi
    Camlidag, Ilkay
    Harman, Mustafa
    Danaci, Murat
    Tuna, Burcin
    Yorukoglu, Kutsal
    Secil, Mustafa
    [J]. DIAGNOSTIC AND INTERVENTIONAL RADIOLOGY, 2019, 25 (01) : 5 - 13
  • [35] Carbonic anyhdrase II in oncocytoma and chromophobe renal cell carcinoma
    Weinrach, DM
    Wang, KL
    Papavero, V
    Lin, B
    Teh, BT
    Yang, XJ
    [J]. MODERN PATHOLOGY, 2005, 18 : 172A - 172A
  • [36] CT differentiation of the oncocytoma and renal cell carcinoma based on peripheral tumor parenchyma and central hypodense area characterisation
    Qu, Jianyi
    Zhang, Qianqian
    Song, Xinhong
    Jiang, Hong
    Ma, Heng
    Li, Wenhua
    Wang, Xiaofei
    [J]. BMC MEDICAL IMAGING, 2023, 23 (01)
  • [37] A CT-based deep learning radiomics nomogram outperforms the existing prognostic models for outcome prediction in clear cell renal cell carcinoma: a multicenter study
    Pei Nie
    Guangjie Yang
    Yanmei Wang
    Yuchao Xu
    Lei Yan
    Mingxin Zhang
    Lianzi Zhao
    Ning Wang
    Xia Zhao
    Xianjun Li
    Nan Cheng
    Yicong Wang
    Chengcheng Chen
    Nan Wang
    Shaofeng Duan
    Ximing Wang
    Zhenguang Wang
    [J]. European Radiology, 2023, 33 : 8858 - 8868
  • [38] CT differentiation of the oncocytoma and renal cell carcinoma based on peripheral tumor parenchyma and central hypodense area characterisation
    Jianyi Qu
    Qianqian Zhang
    Xinhong Song
    Hong Jiang
    Heng Ma
    Wenhua Li
    Xiaofei Wang
    [J]. BMC Medical Imaging, 23
  • [39] T1 Stage Clear Cell Renal Cell Carcinoma: A CT-Based Radiomics Nomogram to Estimate the Risk of Recurrence and Metastasis
    Kang, Bing
    Sun, Cong
    Gu, Hui
    Yang, Shifeng
    Yuan, Xianshun
    Ji, Congshan
    Huang, Zhaoqin
    Yu, Xinxin
    Duan, Shaofeng
    Wang, Ximing
    [J]. FRONTIERS IN ONCOLOGY, 2020, 10
  • [40] Useful markers for differential diagnosis of oncocytoma, chromophobe renal cell carcinoma and conventional renal cell carcinoma
    Geramizadeh, Bita
    Ravanshad, Mahmoud
    Rahsaz, Marjan
    [J]. VIRCHOWS ARCHIV, 2008, 452 : S266 - S266